Shrinking Genes - MDA Research for DMD Treatment

  • Thread starter wasteofo2
  • Start date
  • Tags
    Genes
In summary: They were able to reduce the size of the gene down to a fraction of its original size, while still being able to produce the protein it was originally designed to.
  • #1
wasteofo2
478
2
this is an exerpt from this article: http://www.mdausa.org/publications/Quest/q92resup.cfm#mdasgenetherapy


"Meanwhile, MDA is also laying the groundwork for a clinical trial of AAV-based gene therapy for Duchenne muscular dystrophy (DMD). DMD results from any of a number of mutations in a large gene for the muscle protein known as dystrophin. The full-size gene can't be packaged inside an AAV vector.

To overcome this problem, MDA grantee Jeffrey Chamberlain, a molecular biologist at the University of Washington in Seattle, has developed highly miniaturized dystrophin genes that lead to the production of small proteins. Studies using these microdystrophin genes, which were published in the March issue of Nature Medicine, showed extremely promising results in correcting muscle abnormalities in dystrophin-deficient mice."

I'm shocked. I had no idea that genes, or anything of that sort could be shrunken at all, and the way which they say it makes it sound like a relatively easy thing to do. Has anyone ever heard of a process able to shrink down genes, or any other parts of cells? Would it be at all possible to shrink organelles, or perhaps make a virus which would alter the genes of a cell to make everything smaller as a whole when it divides?
 
Last edited by a moderator:
Biology news on Phys.org
  • #2
They didn't literally shrink any genes. What they did was make a new gene that contained only pieces of the original gene, after they found that only certain parts of the gene produced the protein functions they wanted. This has nothing to do with making cells, or parts of cells, smaller.

For a few more details, see here:

http://www.pitt.edu/utimes/issues/33/010111/research.html
 
Last edited by a moderator:
  • #3
So... if I understand correctly basically they got rid of all the introns, enhancer sites that weren't strictly needed, proteins that weren't strictly needed, and a bunch of other redundant junk?

Pretty clever actually.
 

Related to Shrinking Genes - MDA Research for DMD Treatment

1. What is DMD?

DMD stands for Duchenne muscular dystrophy, which is a genetic disorder that primarily affects males. It is caused by a mutation in the gene that codes for the protein dystrophin, resulting in progressive muscle weakness and degeneration.

2. How does MDA research contribute to DMD treatment?

The Muscular Dystrophy Association (MDA) funds research to find treatments and cures for muscular dystrophy and related neuromuscular diseases. This includes funding research on DMD, which has led to the development of potential treatments such as gene therapy and exon skipping.

3. What are "shrinking genes" in relation to DMD?

"Shrinking genes" refers to the process of using gene therapy to deliver a functional copy of the dystrophin gene to individuals with DMD. This can potentially restore the production of dystrophin protein in muscle cells and slow the progression of the disease.

4. Are there any current treatments for DMD?

Currently, there is no cure for DMD. However, there are treatments that can help manage the symptoms and improve quality of life, such as corticosteroids to slow muscle degeneration and physical therapy to maintain muscle strength.

5. What are the challenges in developing a treatment for DMD?

Some of the challenges in developing a treatment for DMD include the complexity of the genetic mutation, the need for targeted delivery of treatments to muscle cells, and the potential for immune reactions to gene therapy. Additionally, clinical trials for new treatments can be lengthy and expensive.

Similar threads

Back
Top